Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Katz

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Circulation|December 15, 1996
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trialL S Marcus, D Hart, M Packer, et al.
Circulation|April 1, 1997
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failureL Demopoulos, M Yeh, M Gentilucci, et al.
Physical Review Letters|June 25, 2021
Lattice QCD Equation of State at Finite Chemical Potential from an Alternative Expansion SchemeS Borsányi, Z Fodor, J N Guenther, et al.
Pediatric Neurosurgery|January 1, 1990
Cytological and cytoarchitectural changes in the feline cerebral cortex during experimental infantile hydrocephalusL C Wright, J P McAllister, S D Katz, et al.
Journal of Cardiovascular Pharmacology|October 23, 1997
Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failureG Hamroff, I Blaufarb, D Mancini, et al.
Journal of the American College of Cardiology|April 1, 1992
Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failureS D Katz, L Biasucci, C Sabba, et al.
Circulation|March 2, 1999
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failureG Hamroff, S D Katz, D Mancini, et al.
American Heart Journal|January 1, 1992
A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failureS D Katz, S H Kubo, M Jessup, et al.
Science (New York, N.Y.)|March 28, 2015
Ab initio calculation of the neutron-proton mass differenceSz Borsanyi, S Durr, Z Fodor, et al.
Circulation|September 15, 1995
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failureH Krum, J D Sackner-Bernstein, R L Goldsmith, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Circulation|December 15, 1996
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trialL S Marcus, D Hart, M Packer, et al.
Circulation|April 1, 1997
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failureL Demopoulos, M Yeh, M Gentilucci, et al.
Physical Review Letters|June 25, 2021
Lattice QCD Equation of State at Finite Chemical Potential from an Alternative Expansion SchemeS Borsányi, Z Fodor, J N Guenther, et al.
Pediatric Neurosurgery|January 1, 1990
Cytological and cytoarchitectural changes in the feline cerebral cortex during experimental infantile hydrocephalusL C Wright, J P McAllister, S D Katz, et al.
Journal of Cardiovascular Pharmacology|October 23, 1997
Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failureG Hamroff, I Blaufarb, D Mancini, et al.
Journal of the American College of Cardiology|April 1, 1992
Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failureS D Katz, L Biasucci, C Sabba, et al.
Circulation|March 2, 1999
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failureG Hamroff, S D Katz, D Mancini, et al.
American Heart Journal|January 1, 1992
A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failureS D Katz, S H Kubo, M Jessup, et al.
Science (New York, N.Y.)|March 28, 2015
Ab initio calculation of the neutron-proton mass differenceSz Borsanyi, S Durr, Z Fodor, et al.
Circulation|September 15, 1995
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failureH Krum, J D Sackner-Bernstein, R L Goldsmith, et al.
Pageof 6